Home > Insider Trading > Filing (0001209191-13-001577)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1339455	Somaxon Pharmaceuticals Inc.	SOMX	Pharmaceutical Preparations (2834)	200161599

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1457013	Tran Nguyen	Somaxon Pharmaceuticals, Inc. 440 Stevens Avenue, Suite 200 Solana Beach CA 92075	Svp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-12-31	1,494	$0.00	50,361	No	4	A	Direct
Common Stock	Disposition	2013-01-02	412	$3.08	49,949	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

These RSUs were granted in lieu of a portion of the Participant's salary from the quarter ended December 31, 2012. Subject to the terms of the Restricted Stock Unit Agreement, 100% of the RSU Award shall vest upon the earlier of (a) the time that is immediately prior to the consummation of the merger contemplated by the Agreement and Plan of Merger by and among the Company, Pernix Therapeutics Holdings, Inc. and Pernix Acquisition Corp. I dated as of December 10, 2012 (the "Merger Agreement"), or (b) the first date included within an open trading window under the Company's Insider Trading Policy following any termination of the Merger Agreement, subject in either case to Participant's continued status as an Employee, Independent Director or Consultant (each as defined in the Plan) of the Company or any Subsidiary on such vesting date.
This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.